Oxford/AstraZeneca Covid vaccine: What to consider if you're

Oxford/AstraZeneca Covid vaccine: What to consider if you're over 30 and offered the jab


The syndrome has been reported in people aged from 18 to 79. Of those, 51 were women and 28 were men. There is some evidence the risk of the side effect decreases as people get older. However, the main reason for drawing a line at age 30 and below relates not to a person's increased risk of the side-effect - it is after all exceedingly rare - it's to do with the balance of risk and benefit of having the vaccine.
Regulators have concluded that above the age of 30, the risk of serious harm or death from Covid is higher than the very small risk of a potentially fatal blood clot. Below the age of 30, the risk of dying from Covid, if infected, is less than one in 2,500. And of course, the risk is lower still because not everyone gets infected.

Related Keywords

United Kingdom , Britain , Oxford Astrazeneca , Tom Clarke , Astrazeneca , World Health Organization Covax , University Of Oxford , Committee On Vaccination , Editor Tom Clarke , Editor Tom , World Health Organization , Professor Wei Shen Lim , Joint Committee , Prime Minister , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டன் , டோம் கிளார்க் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , குழு ஆன் தடுப்பூசி , ஆசிரியர் டோம் கிளார்க் , ஆசிரியர் டோம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ப்ரொஃபெஸர் வெய் ஷென் லிம் , கூட்டு குழு , ப்ரைம் அமைச்சர் ,

© 2025 Vimarsana